Academic Journal
Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy in patients with asthma: REACH study design
| العنوان: | Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy in patients with asthma: REACH study design |
|---|---|
| المؤلفون: | Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami, Norihiko Kondo |
| المصدر: | ERJ Open Research, Vol 9, Iss 2 (2023) |
| بيانات النشر: | European Respiratory Society, 2023. |
| سنة النشر: | 2023 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | Medicine |
| الوصف: | Cough is a major symptom in patients with asthma and poses a significant burden compared with other asthma symptoms. However, there are no approved treatments in Japan, developed to specifically treat cough in patients with asthma. We present the design of REACH, an 8-week real-life study, which will evaluate the efficacy of a combination of indacaterol acetate, glycopyrronium bromide and mometasone furoate (IND/GLY/MF) in asthmatic patients with cough refractory to medium-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA). Patients with asthma (age ≥20 to |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 2312-0541 23120541 |
| Relation: | http://openres.ersjournals.com/content/9/2/00452-2022.full; https://doaj.org/toc/2312-0541 |
| DOI: | 10.1183/23120541.00452-2022 |
| URL الوصول: | https://doaj.org/article/457bd4aa7f4a4fbebd0ec7f86c9bb821 |
| رقم الانضمام: | edsdoj.457bd4aa7f4a4fbebd0ec7f86c9bb821 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 23120541 |
|---|---|
| DOI: | 10.1183/23120541.00452-2022 |